Cargando…

Correction for: Development and validation of a RNA binding protein-associated prognostic model for lung adenocarcinoma

Detalles Bibliográficos
Autores principales:	Li, Wei, Gao, Li-Na, Song, Pei-Pei, You, Chong-Ge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993732/ https://www.ncbi.nlm.nih.gov/pubmed/33744872 http://dx.doi.org/10.18632/aging.202826

Ejemplares similares

Development and validation of a RNA binding protein-associated prognostic model for lung adenocarcinoma
por: Li, Wei, et al.
Publicado: (2020)

Integrated analysis of the roles and prognostic value of RNA binding proteins in lung adenocarcinoma
por: Li, Wei, et al.
Publicado: (2020)

Integrated Analysis of the Functions and Prognostic Values of RNA Binding Proteins in Lung Squamous Cell Carcinoma
por: Li, Wei, et al.
Publicado: (2020)

Correction: Construction and validation of a prognostic model of RNA binding proteins in clear cell renal carcinoma
por: Han, Wenkai, et al.
Publicado: (2022)

Development and validation of a combined ferroptosis and immune prognostic signature for lung adenocarcinoma
por: Li, Han, et al.
Publicado: (2022)

Correction to: SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma
por: Zhang, Xiuao, et al.
Publicado: (2022)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
por: Sun, Sijin, et al.
Publicado: (2020)

Correction to: CCDC12 promotes tumor development and invasion through the Snail pathway in colon adenocarcinoma
por: Du, Fengying, et al.
Publicado: (2022)

Correction to: The RNA binding protein RBMS3 inhibits the metastasis of breast cancer by regulating Twist1 expression
por: Zhu, Lei, et al.
Publicado: (2020)

Correction for: Integrative analysis of exosomal microRNA-149-5p in lung adenocarcinoma
por: Tian, Wen, et al.
Publicado: (2022)

Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
por: Xu, Yan, et al.
Publicado: (2021)

Construction and validation of an angiogenesis-related lncRNA prognostic model in lung adenocarcinoma
por: Gong, Quan, et al.
Publicado: (2023)

Correction: DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis
por: Liu, Qian, et al.
Publicado: (2022)

Correction: STK11 and KEAP1 mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort
Publicado: (2020)

Development and Validation of a Prognostic Index Based on Genes Participating in Autophagy in Patients With Lung Adenocarcinoma
por: Wu, Zi-Xuan, et al.
Publicado: (2022)

Correction to: GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma
por: Ning, Jing, et al.
Publicado: (2021)

Correction: BCAT1 binds the RNA-binding protein ZNF423 to activate autophagy via the IRE1-XBP-1-RIDD axis in hypoxic PASMCs
por: Xin, Wei, et al.
Publicado: (2021)

Correction to: Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells
por: Zhang, Peng-Fei, et al.
Publicado: (2020)

Correction: Development, Calibration, and Validation of a U.S. White Male Population-Based Simulation Model of Esophageal Adenocarcinoma
por: Hur, Chin, et al.
Publicado: (2010)

Development and validation of a prediction model for lung adenocarcinoma based on RNA-binding protein
por: Yang, Longjun, et al.
Publicado: (2021)

Author Correction: Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma
por: Han, Xiangkun, et al.
Publicado: (2022)

Correction to: Functional and clinical significance of ROR1 in lung adenocarcinoma
por: Schiavone, Giovanna, et al.
Publicado: (2020)

Correction: Immunohistochemical Typing of Adenocarcinomas of the Pancreatobiliary System Improves Diagnosis and Prognostic Stratification
por: Fernández Moro, Carlos, et al.
Publicado: (2017)

Correction: Molecular predictors of brain metastasis-related microRNAs in lung adenocarcinoma
por: Sun, Guogui, et al.
Publicado: (2020)

Publisher Correction: EFHD2 promotes epithelial-to-mesenchymal transition and correlates with postsurgical recurrence of stage I lung adenocarcinoma
por: Fan, Chi-Chen, et al.
Publicado: (2018)

Development and validation of a 4-gene combination for the prognostication in lung adenocarcinoma patients
por: Yin, Xiao-Hong, et al.
Publicado: (2020)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Correction to: Butyrophilin-like 9 expression is associated with outcome in lung adenocarcinoma
por: Ma, Weishuang, et al.
Publicado: (2021)

Correction to: Effect of brain radiotherapy strategies on prognosis of patients with EGFR-mutant lung adenocarcinoma with brain metastasis
por: Deng, Guangchuan, et al.
Publicado: (2021)

Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma
por: Zhang, Anran, et al.
Publicado: (2021)

Correction: Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma
por: Gruber, Elisabeth S., et al.
Publicado: (2020)

Correction: THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma
por: Gimotty, Phyllis A., et al.
Publicado: (2022)

Correction: High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma
por: Zhou, Shijie, et al.
Publicado: (2018)

Correction: Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis
por: Hsu, Ya-Ling, et al.
Publicado: (2019)

Correction: Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma
Publicado: (2017)

Correction: RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma
por: Jiang, Xueping, et al.
Publicado: (2022)

Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Lung Adenocarcinoma
por: Huang, Hua, et al.
Publicado: (2022)

Correction to: Development of a novel TLR8 agonist for cancer immunotherapy
por: Wang, Yuxun, et al.
Publicado: (2021)

Correction: Diagnostic and prognostic utilities of humoral fibulin-3 in malignant pleural mesothelioma: Evidence from a meta-analysis
por: Pei, Dongxu, et al.
Publicado: (2018)

Development and Validation of a Prognostic Gene-Expression Signature for Lung Adenocarcinoma
por: Park, Yun-Yong, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_loejs421ks577g4r098gemq1v5